Just one day before the patent fell in India, Novo Nordisk received US FDA approval for a higher-dose version of Wegovy Wegovy HD, with its higher dose and superior clinical data, was FDA-approved the day before the patent fell, and 49 downstream patents protect its delivery systems through 2042
Three things are true simultaneously: the gray market created by the 2023 restrictions poses real risks to patients
Typical timeline for nausea on Wegovy: Weeks 15: Nausea is most likely to occur Weeks 620: Nausea may continue through month five, especially when dosages are increased Weeks 20+: Nausea should lessen in frequency and intensity In particular, research suggests that nausea is most common during the first 45 weeks
The GLP1R drug class (e.g
08 Severe abdominal pain, jaundice, or unrelenting vomiting Stop the next dose and seek qualified medical care